Skip to content

Company information lookup

BENITEC BIOPHARMA LIMITED (BLT)

Biotechnology, research and development.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BLT 0.780 4.7% 0.760 0.780 0.745 0.780 0.710 163,705

BENITEC BIOPHARMA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BLT
Securities
Official Listing Date 17 February, 1997
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.benitec.com
Registered Office Address Level 16, 356 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (02) 9555 6986
Head Office Fax (03) 8678 1342
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Peter Francis (Non Exec. Chairman)
Dr Peter French (Managing Director, CEO)
Mr Kevin Buchi (Non Exec. Director)
Dr John Chiplin (Non Exec. Director)
Mr Iain Ross (Non Exec. Director)
Company Secretary Mr Greg West
Principal Activities Biotechnology, research and development.

BENITEC BIOPHARMA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
25/11/2014   BENITEC FILES APPEAL TO GRAHAM PATENT IN EUROPE 1 PDF
21/11/2014   CEO & MD ADDRESS TO NEW YORK SHAREHOLDERS 7 PDF
13/11/2014   Results of Meeting 1 PDF
13/11/2014   AGM CEO AND MD ADDRESS 9 PDF
13/11/2014   Chairman's Address to Shareholders 4 PDF
13/11/2014 asterix SECOND PATIENT DOSED IN TT034 TRIAL 2 PDF
11/11/2014 asterix Response to ASX price query 3 PDF
03/11/2014 asterix PAIN LICENSE AND TT034 RESPONSE 2 PDF
31/10/2014   SHAREHOLDER INFORMATION SESSIONS AND WEBCAST 2 PDF
31/10/2014 asterix Appendix 4C - quarterly 6 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
25 Nov 2014 0.745 0.68% 0.750 0.690 184,434
24 Nov 2014 0.740 0.68% 0.770 0.730 131,457
21 Nov 2014 0.735 8.89% 0.770 0.680 283,855
20 Nov 2014 0.675 -1.46% 0.710 0.645 221,681
19 Nov 2014 0.685 9.6% 0.730 0.645 538,446

* Volume of shares shown represents only those shares traded on ASX.

BENITEC BIOPHARMA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BLT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BLT

Warrants & Structured Products

No warrants & Structured Products are available over the security BLT